deferasirox oral granules
Generic: deferasirox
Labeler: epic pharma, llcDrug Facts
Product Profile
Brand Name
deferasirox oral granules
Generic Name
deferasirox
Labeler
epic pharma, llc
Dosage Form
GRANULE
Routes
Active Ingredients
deferasirox 90 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
42806-371
Product ID
42806-371_2b205859-07ad-1703-e063-6394a90ac140
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214559
Listing Expiration
2026-12-31
Marketing Start
2022-10-06
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
42806371
Hyphenated Format
42806-371
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
deferasirox oral granules (source: ndc)
Generic Name
deferasirox (source: ndc)
Application Number
ANDA214559 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 90 mg/1
Packaging
- 30 PACKET in 1 CARTON (42806-371-30) / 1 GRANULE in 1 PACKET
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2b205859-07ad-1703-e063-6394a90ac140", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "unii": ["V8G4MOF2V9"], "rxcui": ["1923822", "1923826", "1923828"], "spl_set_id": ["7eda83c3-a282-47f6-9f06-d2f9612f5c5b"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["EPIC PHARMA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 PACKET in 1 CARTON (42806-371-30) / 1 GRANULE in 1 PACKET", "package_ndc": "42806-371-30", "marketing_start_date": "20221006"}], "brand_name": "Deferasirox Oral Granules", "product_id": "42806-371_2b205859-07ad-1703-e063-6394a90ac140", "dosage_form": "GRANULE", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "42806-371", "generic_name": "deferasirox", "labeler_name": "EPIC PHARMA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deferasirox Oral Granules", "active_ingredients": [{"name": "DEFERASIROX", "strength": "90 mg/1"}], "application_number": "ANDA214559", "marketing_category": "ANDA", "marketing_start_date": "20221006", "listing_expiration_date": "20261231"}